Variant position: 166 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 357 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human YRFRCLNVILWLGFWAVQLN VCLSRIYLAAHFPHQVVAGVL
Mouse YGFRCLNVILWLGFWAVQLN VCLSRIYLAAHFPHQVVAGVL
Rat YGFRCLNVVLWLGYWAVQLN VCLSRIYLAAHFPHQVVAGVL
Bovine YRFRCLNVMLWLGFWVVQLN VCLSRIYLAAHFPHQVVAGVL
Cat YRFRCLNVILWLGFWAVQLN VCLSRIYLAAHFPHQVVAGVL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 357 Glucose-6-phosphatase catalytic subunit 1
148 – 168 Helical
176 – 176 Nucleophile
170 – 170 Substrate
115 – 175 SPSGHAMGTAGVYYVMVTSTLSIFQGKIKPTYRFRCLNVILWLGFWAVQLNVCLSRIYLAA -> KDKADLQISVLECHFVVGILGCAAECLSVTNLPCCSFSSSSCCWSPVRHCCCRNFQPHPQH. In isoform 2.
176 – 176 H -> AIKMNSR. Loss of glucose-6-phosphatase activity.
179 – 179 H -> A. Loss of glucose-6-phosphatase activity.
Characterization of the mutations in the glucose-6-phosphatase gene in Israeli patients with glycogen storage disease type 1a: R83C in six Jews and a novel V166G mutation in a Muslim Arab.
Parvari R.; Moses S.; Hershkovitz E.; Carmi R.; Bashan N.;
J. Inherit. Metab. Dis. 18:21-27(1995)
Cited for: VARIANTS GSD1A CYS-83 AND GLY-166;
Glycogen storage disease type 1a in Israel: biochemical, clinical, and mutational studies.
Parvari R.; Lei K.J.; Bashan N.; Hershkovitz E.; Korman S.H.; Barash V.; Lerman-Sagie T.; Mandel H.; Chou J.Y.; Moses S.W.;
Am. J. Med. Genet. 72:286-290(1997)
Cited for: VARIANTS GSD1A CYS-83 AND GLY-166; CHARACTERIZATION OF VARIANT GSD1A GLY-166; FUNCTION; CATALYTIC ACTIVITY;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.